John R. Teerlink, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis(SIGNIFICANT), St. Jude Medical(SIGNIFICANT), Merck & Co., Inc.(MODEST), Verily(MODEST), Amgen(MODEST), Astra Zeneca(SIGNIFICANT), Cytokinetics, Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Bristol-Myers Squibb Company (MODEST), Medtronic, Inc(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), 3ive Labs(MODEST), ViCardia(MODEST), Windtree Therapeutics(MODEST), Cardurion(MODEST), EBR Systems(SIGNIFICANT), Novartis(MODEST)

View Full Disclosure